More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Olmesartan Medoxomil [144689-63-4]

Olmesartan Medoxomil [144689-63-4]

Research Use Only
O4549
LKT Laboratories
Estimated Purity≥98%
Product group Chemicals
€ 114,00
25 mg
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    LKT Laboratories
  • Product Name
    Olmesartan Medoxomil [144689-63-4]
  • Delivery Days Customer
    7
  • Certification
    Research Use Only
  • Estimated Purity
    ≥98%
  • Format
    0.2mg/ml in ethanol, 20mg.ml in DMSO, and 30 mg/ml in DMF, sparingly soluble in aqueous buffers
  • Scientific Description
    AT1 inhibitor.
  • Storage Instruction
    Ambient
  • UNSPSC
    12352200

References

  • You J, Wu J, Jiang G, et al. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice. J Cardiovasc Pharmacol. 2013 Feb;61(2):142-51. PMID: 23188126. Verdecchia P, Angeli F, Repaci S, et al. Comparative assessment of angiotensin receptor blockers in different clinical settings. Vasc Health Risk Manag. 2009;5:939-48. PMID: 19997575. Matsumoto S, Shimodozono M, Miyata R, et al. Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke. Hypertens Res. 2009 Nov;32(11):1015-21. PMID: 19745828. Yamamoto E, Dong YF, Kataoka K, et al. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition. Hypertension. 2008 Sep;52(3):573-80. PMID: 18678790. Brousil JA, Burke JM. Olmesartan medoxomil: an angiotensin II-receptor blocker. Clin Ther. 2003 Apr;25(4):1041-55. PMID: 12809956.